Choosing Healthy Activities and Lifestyle Management Through Portal Support
CHAMPS
Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
2 other identifiers
interventional
229
1 country
1
Brief Summary
The study aims to randomize 250 participants to 1 of 2 arms: a.) an Active Intervention Group (based on the Look AHEAD\* ILI) or b.) a Comparison Group (based on the Look AHEAD DSE Comparison group) to test the hypothesis that a multicomponent, multilevel behavioral weight loss intervention (Active Intervention Group) adapted for different population groups and delivered through Health Information Technology (Health IT) tools via the Electronic Health Record (EHR) patient portal, will result in significantly greater weight loss 12 months after enrollment compared to the Comparison Group. \*The Look AHEAD study was a multi-center, randomized clinical trial involving overweight and obese persons with type 2 diabetes, aimed to determine the effects on the cardiovascular outcomes of an intensive lifestyle intervention (ILI) for weight loss, in comparison to the diabetes support and education intervention (DSE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedStudy Start
First participant enrolled
February 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 20, 2025
November 1, 2025
3.9 years
May 25, 2022
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relative percentage change in weight
This is calculated for each follow-up visit as ((weight at FU visit - baseline weight) / (baseline weight)) × 100%.
12 months
Secondary Outcomes (3)
Relationship of mutlitlevel determinants of health (screening tool) with weight change over time
12 months
Relationship of mutlilevel determinants of health (BRFSS) with weight change over time
12 months
Relationship of multilevel determinants of health (z codes) with weight change over time
12 months
Study Arms (2)
Active Intervention Group
EXPERIMENTALLook AHEAD Intervention program adapted for delivery via Health IT modified for cultural and social norms applicable to different population groups
Comparison Group
ACTIVE COMPARATORLook AHEAD DSE (Diabetes Support and Education) Comparison Group intervention adapted to be delivered via the EHR patient portal with telephonic support
Interventions
The 3 major intervention components are diet, physical activity, and the behavioral modification curriculum. Scheduled interactions are educational podcasts (a series of audiovisual, digital media files) paired with a follow-up phone counseling session with a trained behavioral interventionist. A patient portal message will be sent to participants when a new podcast is posted. Interactive sessions will be weekly (weeks 1-16), biweekly (weeks 17-24), and monthly (weeks 25-52). The goal for weight loss is ≥ 7% of initial weight over the course of 12 months. Participants will restrict caloric intake with the goal of 1,200-1,500 kcal/day for those weighing \< 114 kg and 1,500-1,800 kcal/day for those weighing ≥ 114 kg. The physical activity goal will be for participants to gradually increase to 175-200 minutes of moderate-intensity activity per week by the 24th week. Participants will also be asked to self-monitor their dietary intake and physical activity using the "Lose It!" app.
All participants in the Comparison Group will receive a mandatory 13 contacts per year including 3 informational sessions on nutrition, physical activity and social support and 10 contacts via patient portal or email regarding intervention topics. The Look AHEAD Comparison Group was designed to be realistic, achievable, and an acceptable intervention that encouraged optimal study retention.
Eligibility Criteria
You may qualify if:
- are ≥ 16 years old
- are overweight or obese (BMI ≥ 25 kg/m2)
- have access to the Internet via the computer or use a cellphone with a data-plan access
- are patients at one of the participating practice sites
- are willing to accept a random assignment, and
- are from different population groups (racial / ethnic minority, lower socioeconomic status, or reside in a rural location).
You may not qualify if:
- coronary or cerebrovascular disease events or vascular procedures within the past 6 months
- certain medical conditions that put participants at high risk of adverse events or preclude exercising
- uncontrolled psychiatric disorders
- current substance abuse, including heavy alcohol use ≥ 5 drinks on the same occasion for ≥ 5 days in the past 30 days
- a history of amputation or bariatric surgery or are planning to have bariatric surgery within the next 12 months
- current weight loss medication use
- malignancy within the last 5 years (except skin cancer)
- plans to move out of the area during the next year
- current participation in another clinical trial
- pregnancy or breast feeding or are planning to become pregnant within the next 12 months, and
- instances judged by the investigators' and primary care providers' discretion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tennesseelead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Tennessee Health Science Center / Department of Preventive Medicine
Memphis, Tennessee, 38105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Johnson, MD
University of Tennessee
- PRINCIPAL INVESTIGATOR
Phyllis Richey, PhD
University of Tennessee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The randomized portion of this protocol will employ a blinding design so that the CHAMPS study personnel and investigators who are collecting and assessing outcome data (i.e., weight) will not know a participant's group assignment status (blinded to assignment). Neither the participants, nor the study staff who provide the intervention, will be blinded to assignment. All participants will be asked not to reveal their CHAMPS study group assignment to blinded clinic personnel. All intervention-related information will be kept separately from outcome data and will not be accessible to blinded staff.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2022
First Posted
June 8, 2022
Study Start
February 24, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 20, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Release and share the data no later than the acceptance of publication of the main finding of the final dataset
- Access Criteria
- Contact PI for access criteria
Investigators will prepare and distribute a dataset maintaining confidentiality of individual participants. The final study analytical database will be processed according to HIPAA definitions for public data sharing and participant data will be de-identified using processes such as: removal of identifiers, translation of dates and ages to delta time values, and assignment of random study identifiers. A series of de-identified data files representing the final analytical data set will be available and provided in a standard format that is readable across a variety of applications and operating system platforms. Other documentation may include: data dictionary, data code book, valid variable ranges, protocol, MOP, intervention manual or programs, and any electronic versions of any paper forms that were used. The data release documentation will provide detailed, organized documentation of study variables and clear instructions on how to install and access the data.